Opioid-induced constipation is a different form of constipation that may not respond to OTC laxatives4,6-8

OIC is caused by opioids binding to mu-opioid receptors in the gastrointestinal (GI) tract, significantly slowing GI motility.8,9 Three effects that can contribute to OIC include:

  • Decreased peristaltic motion10
  • Increased fluid absorption from gut10
  • Decreased fluid secretion into gut10
OIC often persists throughout patients’ opioid therapy; it is usually not dependent on dose or duration of opioid use8

You have the power to identify OIC and intervene early to help address the underlying cause

Take a proactive approach to OIC by starting the conversation with your patients. These questions can help to identify OIC:

How many bowel movements are you having per week?

Are you taking OTC laxatives? How many have you tried?

Download the Doctor Discussion Guide to help your patients evaluate and talk about their symptoms.

Download now
IMPORTANT SAFETY INFORMATION
  • RELISTOR tablets and injection are contraindicated in patients with known or suspected mechanical gastrointestinal obstruction and patients at increased risk of recurrent obstruction, due to the potential for gastrointestinal perforation.
INDICATIONS
  • RELISTOR® is an opioid antagonist. RELISTOR tablets and RELISTOR injection are indicated for the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation.
IMPORTANT SAFETY INFORMATION
  • RELISTOR tablets and injection are contraindicated in patients with known or suspected mechanical gastrointestinal obstruction and patients at increased risk of recurrent obstruction, due to the potential for gastrointestinal perforation.